Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine
- PMID: 2569622
- DOI: 10.1016/s0140-6736(89)90619-3
Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine
Similar articles
-
Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience.An Bras Dermatol. 2018 Mar;93(2):299-301. doi: 10.1590/abd1806-4841.20187162. An Bras Dermatol. 2018. PMID: 29723355 Free PMC article.
-
Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone.J Am Acad Dermatol. 2007 May;56(5):869-71. doi: 10.1016/j.jaad.2006.12.018. Epub 2007 Feb 5. J Am Acad Dermatol. 2007. PMID: 17276544
-
Topical diphencyprone immunotherapy for cutaneous metastatic melanoma.Australas J Dermatol. 2009 Nov;50(4):266-71. doi: 10.1111/j.1440-0960.2009.00556.x. Australas J Dermatol. 2009. PMID: 19916970
-
Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma.J Surg Oncol. 2014 Mar;109(4):308-13. doi: 10.1002/jso.23506. Epub 2013 Nov 19. J Surg Oncol. 2014. PMID: 24522938 Review.
-
Efficacy of topical diphencyprone for melanoma in-transit metastases: a systematic review and meta-analysis.Melanoma Res. 2023 Oct 1;33(5):434-436. doi: 10.1097/CMR.0000000000000914. Epub 2023 Aug 29. Melanoma Res. 2023. PMID: 37650727 No abstract available.
Cited by
-
Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy.Ann Surg Oncol. 2021 Feb;28(2):1029-1038. doi: 10.1245/s10434-020-08713-1. Epub 2020 Jun 15. Ann Surg Oncol. 2021. PMID: 32542563 Free PMC article.
-
Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience.An Bras Dermatol. 2018 Mar;93(2):299-301. doi: 10.1590/abd1806-4841.20187162. An Bras Dermatol. 2018. PMID: 29723355 Free PMC article.
-
Topical diphencyprone as an effective treatment for cutaneous metastatic melanoma.Ann Dermatol. 2012 Aug;24(3):373-5. doi: 10.5021/ad.2012.24.3.373. Epub 2012 Jul 25. Ann Dermatol. 2012. PMID: 22879730 Free PMC article. No abstract available.
-
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD007814. doi: 10.1002/14651858.CD007814.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895966 Free PMC article.
-
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data.Mol Med. 2019 Jun 20;25(1):30. doi: 10.1186/s10020-019-0098-x. Mol Med. 2019. PMID: 31221082 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical